
To explore the zzso safety and zzso of zzso after oral administration of zzso a novel zzso zzso zzso in combination with zzso A zzso in patients with advanced zzso Seven patients were enrolled and randomly assigned to receive oral zzso zzso 160 zzso 700 zzso on day 1, followed by oral zzso zzso 160 zzso 700 zzso on day 8 zzso I) or vice versa zzso zzso Patients received zzso zzso 160 zzso as zzso infusion on day zzso The median zzso area under the plasma zzso curve of zzso was zzso zzso zzso h zzso and zzso zzso zzso h zzso after oral administration of zzso and zzso respectively, and zzso zzso zzso h zzso after intravenous zzso zzso zzso resulted in a lower median zzso of zzso zzso h than orally applied zzso zzso zzso zzso zzso The median apparent zzso of zzso was 40 zzso and 55 zzso for the oral zzso and oral zzso zzso zzso zzso zzso administered as zzso or zzso was safe and well tolerated by the zzso zzso the zzso zzso resulted in a significantly lower zzso than orally applied zzso probably due to the zzso in the zzso zzso resulting in a higher zzso rate of zzso 

